UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000048936
Receipt No. R000055754
Scientific Title Relationship between periodontitis and mild cognitive impairment: Pilot intervention study
Date of disclosure of the study information 2022/09/30
Last modified on 2022/09/15 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Relationship between periodontitis and mild cognitive impairment
Acronym Relationship between periodontitis and mild cognitive impairment
Scientific Title Relationship between periodontitis and mild cognitive impairment: Pilot intervention study
Scientific Title:Acronym Relationship between periodontitis and mild cognitive impairment
Region
Japan

Condition
Condition Periodontitis and mild cognitive impairment
Classification by specialty
Psychiatry Dental medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to elucidate the relationship between periodontitis and mild cognitive impairment.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Mini-Mental State Examination (MMSE)
(Before the beginning of periodontitis treatment and 24 weeks after the beginning of periodontitis treatment)
Key secondary outcomes Montreal Cognitive Assessment (MoCA)
Clock Drawing Test (CDT)

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Maneuver
Interventions/Control_1 Periodontitis treatment (mostly 3 times in 24 weeks)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
60 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Diagnosed as mild cognitive impairment
(MMSE 24-27, and MoCA 25 or less)
Key exclusion criteria 1)Received anti-dementia drug treatment or periodontal disease treatment within the past 6 months
2)edentulous person
3)Hypertension, untreated at the time of consent
4)Hyperlipidemia, untreated at time of consent
5)diabetes mellitus, untreated at time of consent
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Sadayuki
Middle name
Last name Hashioka
Organization Asahikawa Medical University
Division name Department of Psychiatry
Zip code 078-8510
Address 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido
TEL 0166-68-2473
Email hashioka@asahikawa-med.ac.jp

Public contact
Name of contact person
1st name Shinsuke
Middle name
Last name Yoshihara
Organization Asahikawa Medical University
Division name Department of Psychiatry
Zip code 078-8510
Address 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido
TEL 0166-68-2473
Homepage URL
Email syoshi@asahikawa-med.ac.jp

Sponsor
Institute Asahikawa Medical University
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Asahikawa Medical University Research Ethics Committee
Address 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido
Tel 0166-68-2297
Email rs-kk.g@asahikawa-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 09 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 09 Month 12 Day
Date of IRB
Anticipated trial start date
2022 Year 10 Month 01 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 09 Month 14 Day
Last modified on
2022 Year 09 Month 15 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055754